Sanofi India Limited

Update in progress

SANOFI.NS (NSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - General

Sanofi India Limited manufactures and markets pharmaceutical products in India, Singapore and worldwide. It covers therapies such as diabetes, cardiology, infections, CNS, allergy, pain, digestive and nutrition. Brands include Lantus, Toujeo, Soliqua, Clexane, Amaryl, Combiflam, Allegra, Dulcoflex and more, via independent distributors. Exports reach about 24 countries. Formerly Aventis Pharma, renamed in 2012. Founded 1956, based in Mumbai; subsidiary of Hoechst GmbH.

Company score

Sentiment: -0.06; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.14; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.08; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.06; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.06; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive